Descriptor English: | Chemotherapy-Related Cognitive Impairment | ||||||
Descriptor Spanish: |
Deterioro Cognitivo Relacionado con la Quimioterapia
| ||||||
Descriptor Portuguese: | Comprometimento Cognitivo Relacionado à Quimioterapia | ||||||
Descriptor French: | Altération cognitive liée à la chimiothérapie | ||||||
Entry term(s): |
Chemo Fog Chemo-Fog Chemobrain Chemotherapy Induced Cognitive Dysfunction Chemotherapy Induced Cognitive Impairment Chemotherapy Induced Cognitive Impairments Chemotherapy Related Cognitive Dysfunction Chemotherapy Related Cognitive Impairment Chemotherapy-Induced Cognitive Dysfunction Chemotherapy-Induced Cognitive Impairment Chemotherapy-Induced Cognitive Impairments Chemotherapy-Related Cognitive Dysfunction Chemotherapy-Related Cognitive Dysfunctions Chemotherapy-Related Cognitive Impairments Cognitive Dysfunction, Chemotherapy-Induced Cognitive Dysfunction, Chemotherapy-Related Cognitive Impairment, Chemotherapy-Induced Cognitive Impairment, Chemotherapy-Related Cognitive Impairments, Chemotherapy-Induced Cognitive Impairments, Chemotherapy-Related |
||||||
Tree number(s): |
C25.100.429 F03.615.250.700.250 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000084202 | ||||||
Scope note: | The diminished or impaired mental and/or intellectual function associated with the chemical treatment of cancer. |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation SU surgery TH therapy UR urine VI virology |
||||||
Previous Indexing: |
Cognitive Dysfunction (2004-2020) |
||||||
Public MeSH Note: | 2021 |
||||||
History Note: | 2021 |
||||||
DeCS ID: | 59412 | ||||||
Unique ID: | D000084202 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2021/01/01 | ||||||
Date of Entry: | 2020/07/07 | ||||||
Revision Date: | 2020/06/22 |
-
PSYCHIATRY AND PSYCHOLOGY
Mental Disorders [F03]Mental Disorders
|
Chemotherapy-Related Cognitive Impairment
- Preferred
Concept UI |
M000681638 |
Scope note | The diminished or impaired mental and/or intellectual function associated with the chemical treatment of cancer. |
Preferred term | Chemotherapy-Related Cognitive Impairment |
Entry term(s) |
Chemo Fog Chemo-Fog Chemobrain Chemotherapy Induced Cognitive Dysfunction Chemotherapy Induced Cognitive Impairment Chemotherapy Induced Cognitive Impairments Chemotherapy Related Cognitive Dysfunction Chemotherapy Related Cognitive Impairment Chemotherapy-Induced Cognitive Dysfunction Chemotherapy-Induced Cognitive Impairment Chemotherapy-Induced Cognitive Impairments Chemotherapy-Related Cognitive Dysfunction Chemotherapy-Related Cognitive Dysfunctions Chemotherapy-Related Cognitive Impairments Cognitive Dysfunction, Chemotherapy-Induced Cognitive Dysfunction, Chemotherapy-Related Cognitive Impairment, Chemotherapy-Induced Cognitive Impairment, Chemotherapy-Related Cognitive Impairments, Chemotherapy-Induced Cognitive Impairments, Chemotherapy-Related |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey